Accurate information on Japanese medicine,smoother conversations on site
We provide source-based information on proton therapy, head and neck cancer, photoimmunotherapy, nucleic acid medicine and NK cells, and support interpretation on site in Japan.
FTH is not a medical institution. We provide medical information guidance and interpretation support.
AI-generated staged image · not real people
Connecting source-based information with on-site communication
FTH checks materials published by Japanese medical institutions and organizes them with sources. Treatment choice and suitability are decided by the medical team; FTH narrows the gap in information and language along the way.
Source-based medical information
We check public materials directly and separate institutional descriptions, authoritative sources and unconfirmed points.
Document translation and terminology support
We translate Japanese notices and explanatory materials and help you understand medical terms.
On-site interpretation and communication
During clinic visits we support interpretation so that the medical team’s explanations and your questions are conveyed accurately.
Five topics of Japan medical information
For each topic we checked the designated source directly and labelled institutional descriptions, authoritative sources, limited evidence and unconfirmed points.
Proton Therapy Information in Japan
Basic concepts of proton therapy, Japan’s public insurance coverage, and the equipment and care system published by the designated institution.
View info
Head and Neck Cancer Information in Japan
Method and points to confirm for selective intra-arterial chemoradiotherapy as described for oral and tongue cancer.
View info
Photoimmunotherapy-related Information in Japan
The actual drugs and device behind what the clinic calls “photoimmunotherapy”, with approval status and cost separated.
View info
Nucleic Acid Medicine & Aptamer Information in Japan
Separates the broad category of nucleic acid medicines from the specific aptamer method used by the designated clinic.
View info
NK Cell-related Information in Japan
The difference between NK cell therapy and immune function assessment, self-pay status, and limitations the clinic states.
View info
Other Japanese medical information
Heavy-ion (carbon-ion) therapy, IVR and RFA, summarised from materials published by the named institutions.
View infoSo that conversations flow on site in Japan
We support the communication needed during visits to medical institutions.
Interpretation and translation convey the medical team’s explanations accurately and do not replace medical judgement. Supported languages, regions, format and fees are confirmed individually on inquiry. The four languages of this website do not indicate the languages available for interpretation.
From inquiry to on-site support
We confirm the scope of support in the following order. Anything requiring medical judgement is decided by the medical institution.
Info & interpretation inquiry
Tell us by phone, email or form what information or interpretation you need. No detailed medical history is needed at first.
Confirm scope and schedule
We confirm what FTH can support, the visit schedule, interpretation format and fees.
Prepare documents and terms
Before the visit, we organize the documents requested by the institution and your questions, and align key terms.
On-site interpretation
On the day, we interpret the medical team’s explanations and your questions. Treatment decisions are made by you and the medical team.
Confirm the scope of information and interpretation first
We provide guidance on organizing public information from Japanese medical institutions, translating medical documents and interpreting during visits. We do not diagnose or recommend treatment.
Articles that read the sources and answer real questions
Proton therapy in Japan: first separate insurance, Advanced Medical Care and self-pay
Proton therapy in Japan falls under public insurance, Advanced Medical Care or self-pay depending on the condition. Here is what to distinguish before reading institutional information.
Read moreReading information on selective intra-arterial chemoradiotherapy for tongue cancer — starting with its scope
Same name “photoimmunotherapy”, not the same treatment
Nucleic acid medicine and aptamers: start by separating the terms
